Anteris Technologies Ltd (AVR.AX)
AUD 7.5
(-9.64%)
AUD 7.5
(-9.64%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 4.11 Million AUD | -10.43% |
| 2022 | 4.59 Million AUD | -41.08% |
| 2021 | 7.79 Million AUD | 10.06% |
| 2020 | 7.07 Million AUD | -58.54% |
| 2019 | 17.07 Million AUD | -33.3% |
| 2018 | 25.6 Million AUD | 13.23% |
| 2017 | 22.61 Million AUD | 1.28% |
| 2016 | 22.32 Million AUD | 57.76% |
| 2015 | 14.15 Million AUD | 39.64% |
| 2014 | 10.13 Million AUD | 28.27% |
| 2013 | 7.9 Million AUD | 6.71% |
| 2012 | 7.4 Million AUD | 15.03% |
| 2011 | 6.43 Million AUD | -4.65% |
| 2010 | 6.74 Million AUD | 0.0% |
| 2009 | - AUD | 0.0% |
| 2008 | - AUD | 0.0% |
| 2007 | - AUD | 0.0% |
| 2006 | - AUD | 0.0% |
| 2005 | - AUD | 0.0% |
| 2004 | - AUD | 0.0% |
| 2003 | - AUD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 2.12 Million AUD | 0.0% |
| 2023 Q4 | 1.76 Million AUD | 0.0% |
| 2023 Q2 | 2.34 Million AUD | 0.0% |
| 2023 FY | 4.11 Million AUD | -10.43% |
| 2022 Q4 | 2.1 Million AUD | 0.0% |
| 2022 Q2 | 2.48 Million AUD | 0.0% |
| 2022 FY | 4.59 Million AUD | -41.08% |
| 2021 FY | 7.79 Million AUD | 10.06% |
| 2021 Q2 | 3.17 Million AUD | 0.0% |
| 2021 Q4 | 4.61 Million AUD | 0.0% |
| 2020 Q2 | 3.94 Million AUD | 0.0% |
| 2020 Q4 | 3.12 Million AUD | 0.0% |
| 2020 FY | 7.07 Million AUD | -58.54% |
| 2019 Q2 | 10.7 Million AUD | 0.0% |
| 2019 Q4 | 6.37 Million AUD | 0.0% |
| 2019 FY | 17.07 Million AUD | -33.3% |
| 2018 Q4 | 12.8 Million AUD | 0.0% |
| 2018 FY | 25.6 Million AUD | 13.23% |
| 2018 Q2 | 12.79 Million AUD | 0.0% |
| 2017 FY | 22.61 Million AUD | 1.28% |
| 2017 Q2 | 10.08 Million AUD | 0.0% |
| 2016 Q2 | 7.58 Million AUD | 0.0% |
| 2016 Q4 | 12.24 Million AUD | 0.0% |
| 2016 FY | 22.32 Million AUD | 57.76% |
| 2015 Q4 | 6.56 Million AUD | 0.0% |
| 2015 FY | 14.15 Million AUD | 39.64% |
| 2015 Q2 | 5.33 Million AUD | 0.0% |
| 2014 FY | 10.13 Million AUD | 28.27% |
| 2014 Q2 | 3.85 Million AUD | 0.0% |
| 2014 Q4 | 4.79 Million AUD | 0.0% |
| 2013 FY | 7.9 Million AUD | 6.71% |
| 2013 Q4 | 4.08 Million AUD | 0.0% |
| 2013 Q2 | 3.66 Million AUD | 0.0% |
| 2012 Q2 | 1.6 Million AUD | 0.0% |
| 2012 Q1 | 1.6 Million AUD | 0.0% |
| 2012 FY | 7.4 Million AUD | 15.03% |
| 2012 Q4 | 3.75 Million AUD | 133.25% |
| 2012 Q3 | 1.6 Million AUD | 0.0% |
| 2011 Q2 | 1.68 Million AUD | 0.0% |
| 2011 Q3 | 1.68 Million AUD | 0.0% |
| 2011 Q4 | 1.6 Million AUD | -4.65% |
| 2011 FY | 6.43 Million AUD | -4.65% |
| 2011 Q1 | 1.68 Million AUD | 0.0% |
| 2010 FY | 6.74 Million AUD | 0.0% |
| 2010 Q3 | - AUD | 0.0% |
| 2010 Q4 | 1.68 Million AUD | 0.0% |
| 2010 Q2 | - AUD | 0.0% |
| 2010 Q1 | - AUD | 0.0% |
| 2009 Q3 | - AUD | 0.0% |
| 2009 Q4 | - AUD | 0.0% |
| 2009 Q2 | - AUD | 0.0% |
| 2009 FY | - AUD | 0.0% |
| 2009 Q1 | - AUD | 0.0% |
| 2008 Q3 | - AUD | 0.0% |
| 2008 FY | - AUD | 0.0% |
| 2008 Q4 | - AUD | 0.0% |
| 2008 Q2 | - AUD | 0.0% |
| 2008 Q1 | - AUD | 0.0% |
| 2007 Q1 | - AUD | 0.0% |
| 2007 Q4 | - AUD | 0.0% |
| 2007 FY | - AUD | 0.0% |
| 2007 Q3 | - AUD | 0.0% |
| 2007 Q2 | - AUD | 0.0% |
| 2006 Q3 | - AUD | 0.0% |
| 2006 Q4 | - AUD | 0.0% |
| 2006 FY | - AUD | 0.0% |
| 2006 Q1 | - AUD | 0.0% |
| 2006 Q2 | - AUD | 0.0% |
| 2005 Q4 | - AUD | 0.0% |
| 2005 FY | - AUD | 0.0% |
| 2005 Q1 | - AUD | 0.0% |
| 2005 Q2 | - AUD | 0.0% |
| 2005 Q3 | - AUD | 0.0% |
| 2004 Q3 | - AUD | 0.0% |
| 2004 FY | - AUD | 0.0% |
| 2004 Q2 | - AUD | 0.0% |
| 2004 Q4 | - AUD | 0.0% |
| 2004 Q1 | - AUD | 0.0% |
| 2003 FY | - AUD | 0.0% |
| 2003 Q4 | - AUD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| 4DMedical Limited | 3.75 Million AUD | -9.505% |
| Adherium Limited | 840.98 Thousand AUD | -388.843% |
| Aroa Biosurgery Limited | 63.35 Million AUD | 93.511% |
| Atomo Diagnostics Limited | 4.08 Million AUD | -0.601% |
| Control Bionics Limited | 5.12 Million AUD | 19.813% |
| CardieX Limited | 10.9 Million AUD | 62.303% |
| Compumedics Limited | 49.71 Million AUD | 91.731% |
| Cochlear Limited | 2.25 Billion AUD | 99.818% |
| CleanSpace Holdings Limited | 15.72 Million AUD | 73.851% |
| Cyclopharm Limited | 27.13 Million AUD | 84.852% |
| EMVision Medical Devices Ltd | 11.21 Million AUD | 63.357% |
| Nova Eye Medical Limited | 23.32 Million AUD | 82.375% |
| HeraMED Limited | 402.89 Thousand AUD | -920.38% |
| Imricor Medical Systems, Inc. | 615.56 Thousand AUD | -567.852% |
| ImpediMed Limited | 10.31 Million AUD | 60.16% |
| InhaleRx Limited | 1.2 Million AUD | -241.439% |
| LBT Innovations Limited | 1.25 Million AUD | -227.315% |
| Micro-X Limited | 15.22 Million AUD | 72.993% |
| Neurotech International Limited | 1963.00 AUD | -209328.477% |
| OncoSil Medical Limited | 1.56 Million AUD | -162.625% |
| PolyNovo Limited | 103.19 Million AUD | 96.016% |
| Respiri Limited | 456.91 Thousand AUD | -799.749% |
| SomnoMed Limited | 91.65 Million AUD | 95.514% |
| Universal Biosensors, Inc. | 6.63 Million AUD | 38.019% |
| Uscom Limited | 3.72 Million AUD | -10.31% |
| Visioneering Technologies, Inc. | 8.67 Million AUD | 52.583% |